Katie McCauley

Company: Novartis

Job title: Director & Portfolio Strategy & Fibrosis Research Lead

Seminars:

Panel & Audience Discussion: What’s Next for Fibrosis? Understanding the Future Directions of the Antifibrotic Field 3:00 pm

This panel brings together experts from across various disease indications to explore the evolving scientific, translational, and clinical landscape of antifibrotic drug development to provide forward-looking perspective on where antifibrotic science is heading, which challenges are most urgent to overcome, and how industry and academia can collaborate more effectively to accelerate progress across diverse indication.…Read more

day: Conference Day Two

The Big Debate: Pan-Antifibrotics, Fact or Fiction? Dissecting Mechanisms & Organ Specificity & Strategies for Cross-Tissue Success 2:00 pm - 4:00 pm

As interest grows in developing antifibrotics with cross-indication potential, this workshop critically examines whether a true “pan-antifibrotic” is biologically and clinically feasible. Through real-world data, mechanistic comparisons, and forward-looking trial design strategies, we’ll explore what it would take to deliver a truly universal fibrosismodifying therapy. This workshop will gather experts to discuss: Reviewing trials of…Read more

day: Pre-Conference Day